elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34817365-6D16BC20-906A-4CDF-A41B-E5DB6757F8DA
Q34817365-6D16BC20-906A-4CDF-A41B-E5DB6757F8DA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34817365-6D16BC20-906A-4CDF-A41B-E5DB6757F8DA
Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinic
P2860
Q34817365-6D16BC20-906A-4CDF-A41B-E5DB6757F8DA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34817365-6D16BC20-906A-4CDF-A41B-E5DB6757F8DA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1091b1c9ec47fa63c6849f34beb25303308cbd52
P2860
Weekly treatment with bortezomib for patients with recurrent or refractory multiple myeloma: a phase 2 trial of the Minnie Pearl Cancer Research Network.